Suppr超能文献

[Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?].

作者信息

Matschke Klaus, Tugtekin Sems Malte, Kappert Utz, Jung Friedrich, Park Jai-Wun, Knaut Michael

机构信息

Klinik für Herz- und Thorakale Gefässchirurgie, Herzzentrum Dresden GmbH, Universitätsklinik, Dresden.

出版信息

Herz. 2004 Mar;29(2):201-7. doi: 10.1007/s00059-004-2561-9.

Abstract

BACKGROUND

The number of surgical coronary revascularization procedures is static and even declining. Since the introduction of drug eluting stents the question arose whether this will have an impact on the spectrum of surgical coronary revascularization procedures.

BYPASS SURGERY

Bypass surgery is a routine procedure for the treatment of coronary artery disease with good results. Studies have shown that there is a benefit in favor of surgery compared to interventional cardiologic procedures. DRUG-ELUTING STENTS: In recent studies a new generation of stents, drug-eluting stents, have proven to have a significant better patency rate than common stents. However, to date there are no studies which show a benefit compared to surgery given the same indication for treatment.

CONCLUSION

Therefore, the question whether drug-eluting stents have an impact on the spectrum of bypass surgery cannot be fully answered at present.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验